latest update:
[TrialBase DB]

trial summary · NCT07630155

Office-Based Ureteroscopy Utilizing a Single Use Digital, Flexible Ureteroscope for Upper Tract Urothelial Carcinoma

A Prospective Clinical Assessment of Office-Based Ureteroscopy for Upper Tract Urothelial Carcinoma Utilizing a 6.3 French Single Use Digital Flexible Ureteroscope

Trial record from the TrialBase DB dataset, status RECRUITING, condition Renal Pelvis and Ureter Urothelial Carcinoma, sponsored by University of Michigan Rogel Cancer Center. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07630155phase —enrollment 10start 2026-12

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

This clinical trial tests how well office based ureteroscopy utilizing a single use digital, flexible ureteroscope works for the assessment of upper tract urothelial carcinoma. Ureteroscopy is a procedure in which a thin camera called a ureteroscope is used to assess patients with a known or suspected diagnosis of upper tract urothelial carcinoma. Ureteroscopy is traditionally performed in an operating room under general anesthesia. In this study, patients undergo ureteroscopy in the doctor's office using an ultra-thin ureteroscope, which is the narrowest instrument of its kind. Because of its small size, researchers believe this procedure can be completed in the office with minimal discomfort and high patient satisfaction, which may eliminate the risks of general anesthesia and reduce delays to diagnosis. Office based ureteroscopy utilizing a single use digital, flexible ureteroscope may be effective for the assessment of upper tract urothelial carcinoma.

Source record: https://clinicaltrials.gov/study/NCT07630155

Facts

registry idNCT07630155
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionRenal Pelvis and Ureter Urothelial Carcinoma
sponsorUniversity of Michigan Rogel Cancer Center
sponsor classOTHER
enrollment10
start date2026-12
primary completion2027-12
completion2027-12
results postednot reported

Conditions

  • Renal Pelvis and Ureter Urothelial Carcinoma

Interventions

  • Analgesic Agent
  • Electronic Health Record Review
  • Lidocaine Topical
  • Medical Device Usage and Evaluation
  • Survey Administration
  • Ureteroscopy

Countries

  • United States

Intervention types: DEVICE, DRUG, OTHER, PROCEDURE

Work with this record